Works matching IS 0195668X AND DT 2018 AND VI 39 AND IP 27

Results: 21

Are the proprotein convertase subtilisin/kexin type 9 inhibitors new therapeutic chance for patients with familial hypercholesterolaemia and liver failure?

Published in:

European Heart Journal, 2018, v. 39, n. 27, p. 2602, doi. 10.1093/eurheartj/ehy361

By:

Glowczynska, Renata;
Hus, Aleksandra;
Raszeja-Wyszomirska, Joanna;
Opolski, Grzegorz

Publication type:

Article

New prospects for PCSK9 inhibition?

Published in:

European Heart Journal, 2018, v. 39, n. 27, p. 2600, doi. 10.1093/eurheartj/ehy147

By:

Landmesser, Ulf;
Chapman, M John;
Stock, Jane K;
Amarenco, Pierre;
Belch, Jill J F;
Borén, Jan;
Farnier, Michel;
Ference, Brian A;
Gielen, Stephan;
Graham, Ian

Publication type:

Article

Pathological phenotypes of LDL particles.

Published in:

European Heart Journal, 2018, v. 39, n. 27, p. 2574, doi. 10.1093/eurheartj/ehy387

By:

Laufs, Ulrich;
Weingärtner, Oliver

Publication type:

Article

PCSK9 inhibition and Lp(a) reduction: another piece of the puzzle?

Published in:

European Heart Journal, 2018, v. 39, n. 27, p. 2586, doi. 10.1093/eurheartj/ehy311

By:

Pirillo, Angela;
Catapano, Alberico Luigi

Publication type:

Article

Reduction of low density lipoprotein-cholesterol and cardiovascular events with proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors and statins: an analysis of FOURIER, SPIRE, and the Cholesterol Treatment Trialists Collaboration.

Published in:

European Heart Journal, 2018, v. 39, n. 27, p. 2540, doi. 10.1093/eurheartj/ehx450

By:

Ference, Brian A;
Cannon, Christopher P;
Landmesser, Ulf;
Lüscher, Thomas F;
Catapano, Alberico L;
Ray, Kausik K

Publication type:

Article

Russian National Congress of Cardiology 2018.

Published in:: European Heart Journal, 2018, v. 39, n. 27, p. 2525, doi. 10.1093/eurheartj/ehy325
Publication type:: Article

Superior and inferior vena cava obstruction: an unusual presentation of a rare primary cardiac tumour.

Published in:

European Heart Journal, 2018, v. 39, n. 27, p. 2604, doi. 10.1093/eurheartj/ehy349

By:

Kogoj, Polonca;
Zbačnik, Rok;
Dolenc-Stražar, Zvezdana;
Klokočovnik, Tomislav;
Cvijić, Marta

Publication type:

Article

Susceptibility of low-density lipoprotein particles to aggregate depends on particle lipidome, is modifiable, and associates with future cardiovascular deaths.

Published in:

European Heart Journal, 2018, v. 39, n. 27, p. 2562, doi. 10.1093/eurheartj/ehy319

By:

Ruuth, Maija;
Nguyen, Su Duy;
Vihervaara, Terhi;
Hilvo, Mika;
Laajala, Teemu D;
Kondadi, Pradeep Kumar;
Gisterå, Anton;
Lähteenmäki, Hanna;
Kittilä, Tiia;
Huusko, Jenni

Publication type:

Article

‘Highest risk–highest benefit’ strategy: a pragmatic, cost-effective approach to targeting use of PCSK9 inhibitor therapies.

Published in:

European Heart Journal, 2018, v. 39, n. 27, p. 2546, doi. 10.1093/eurheartj/ehx710

By:

Annemans, Lieven;
Packard, Chris J;
Briggs, Andrew;
Ray, Kausik K

Publication type:

Article

‘The lower the better’ revisited: low-density lipoprotein and lipoprotein(a).

Published in:

European Heart Journal, 2018, v. 39, n. 27, p. 2509, doi. 10.1093/eurheartj/ehy444

By:

Lüscher, Thomas F

Publication type:

Article

Variability in atherogenic lipoproteins and coronary artery disease progression.

Published in:

European Heart Journal, 2018, v. 39, n. 27, p. 2559, doi. 10.1093/eurheartj/ehy348

By:

Alfonso, Fernando;
Rivero, Fernando;
Sánchez-Madrid, Francisco

Publication type:

Article

Cardiovascular disease risk associated with elevated lipoprotein(a) attenuates at low low-density lipoprotein cholesterol levels in a primary prevention setting.

Published in:

European Heart Journal, 2018, v. 39, n. 27, p. 2589, doi. 10.1093/eurheartj/ehy334

By:

Verbeek, Rutger;
Hoogeveen, Renate M;
Langsted, Anne;
Stiekema, Lotte C A;
Verweij, Simone L;
Hovingh, G Kees;
Wareham, Nicholas J;
Khaw, Kay-Tee;
Boekholdt, S Matthijs;
Nordestgaard, Børge G

Publication type:

Article

Adverse effects of statin therapy: perception vs. the evidence – focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract.

Published in:

European Heart Journal, 2018, v. 39, n. 27, p. 2526, doi. 10.1093/eurheartj/ehy182

By:

Mach, François;
Ray, Kausik K;
Wiklund, Olov;
Corsini, Alberto;
Catapano, Alberico L;
Bruckert, Eric;
Backer, Guy De;
Hegele, Robert A;
Hovingh, G Kees;
Jacobson, Terry A

Publication type:

Article

Cardiac manifestation of polyarteritis nodosa.

Published in:

European Heart Journal, 2018, v. 39, n. 27, p. 2603, doi. 10.1093/eurheartj/ehy090

By:

Peters, Benjamin;
Spiczak, Jochen von;
Ruschitzka, Frank;
Distler, Oliver;
Manka, Robert;
Alkadhi, Hatem

Publication type:

Article

CIT 2018: A New Era, New JourneyReport from the China Interventional Therapeutics (CIT) 2018, the largest interventional cardiology scientific congress in the Asia-Pacific region.

Published in:

European Heart Journal, 2018, v. 39, n. 27, p. 2515, doi. 10.1093/eurheartj/ehy322

By:

Gao, Runlin

Publication type:

Article

Controlled study of the effect of proprotein convertase subtilisin-kexin type 9 inhibition with evolocumab on lipoprotein(a) particle kinetics.

Published in:

European Heart Journal, 2018, v. 39, n. 27, p. 2577, doi. 10.1093/eurheartj/ehy122

By:

Watts, Gerald F;
Chan, Dick C;
Somaratne, Ransi;
Wasserman, Scott M;
Scott, Rob;
Marcovina, Santica M;
Barrett, P Hugh R

Publication type:

Article

The ESC Publications Ethics CommitteeReport from the first 5 years’ experience of the European Society of Cardiology (ESC) journals family ethics committee.

Published in:

European Heart Journal, 2018, v. 39, n. 27, p. 2518, doi. 10.1093/eurheartj/ehy323

By:

Members, On behalf of all Committee;
Simoons, Maarten L

Publication type:

Article

Hands-on training in acute cardiac careReport from the first-ever Acute Cardiovascular Care School in Madrid, Spain, November 2017.

Published in:

European Heart Journal, 2018, v. 39, n. 27, p. 2521, doi. 10.1093/eurheartj/ehy324

By:

Krychtiuk, Konstantin A;
Asenjo, Roberto Martin;
Bueno, Hector

Publication type:

Article

Visit-to-visit cholesterol variability correlates with coronary atheroma progression and clinical outcomes.

Published in:

European Heart Journal, 2018, v. 39, n. 27, p. 2551, doi. 10.1093/eurheartj/ehy209

By:

Clark, Donald;
Nicholls, Stephen J;
John, Julie St.;
Elshazly, Mohamed B;
Kapadia, Samir R;
Tuzcu, E Murat;
Nissen, Steven E;
Puri, Rishi

Publication type:

Article

Hugo A. Katus MD PhD FESCAfter discovering troponin as a biomarker Katus reached out to genome research, improving healthcare in hospitals, and actively teaching, to fill a 13-hour workday schedule.

Published in:

European Heart Journal, 2018, v. 39, n. 27, p. 2513, doi. 10.1093/eurheartj/ehy321

By:

Ozkan, Judy

Publication type:

Article

Lipoprotein(a): the perpetual supporting actor.

Published in:

European Heart Journal, 2018, v. 39, n. 27, p. 2597, doi. 10.1093/eurheartj/ehy385

By:

Gencer, Baris;
Mach, François

Publication type:

Article